Evaluation of a commercial Real Time PCR for clinical samples without RNA extraction for detection of SARS-CoV-2
- 25 July 2024
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 110 (3) , 116441
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Direct RT-PCR amplification of SARS-CoV-2 from clinical samples using a concentrated viral lysis-amplification buffer prepared with IGEPAL-630Scientific Reports, 2021
- Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirementsJournal of Virological Methods, 2021
- Viral Cultures for Coronavirus Disease 2019 Infectivity Assessment: A Systematic ReviewClinical Infectious Diseases, 2020
- Extraction-free SARS-CoV-2 detection by rapid RT-qPCR universal for all primary respiratory materialsJournal of Clinical Virology, 2020
- Early diagnosis and rapid isolation: response to COVID-19 outbreak in KoreaClinical Microbiology and Infection, 2020
- Virological assessment of hospitalized patients with COVID-2019Nature, 2020
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challengesInternational Journal of Antimicrobial Agents, 2020
- Development of a direct reverse-transcription quantitative PCR (dirRT-qPCR) assay for clinical Zika diagnosisInternational Journal of Infectious Diseases, 2019
- HPV Direct Flow CHIP: A new human papillomavirus genotyping method based on direct PCR from crude-cell extractsJournal of Virological Methods, 2013
- Detection of noroviruses in fecal specimens by direct RT-PCR without RNA purificationJournal of Virological Methods, 2010